FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

30192311000001102: Cangrelor tetrasodium (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    93879301000001115 Cangrelor tetrasodium (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    93879401000001111 Cangrelor tetrasodium en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cangrelor tetrasodium Is a Substance with platelet aggregation inhibitor mechanism of action (substance) false Inferred relationship Existential restriction modifier
    Cangrelor tetrasodium Is a Antiplatelet agent false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Cangrelor 50mg powder for solution for injection vials Has specific active ingredient False Cangrelor tetrasodium Inferred relationship Existential restriction modifier
    Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) Has specific active ingredient False Cangrelor tetrasodium Inferred relationship Existential restriction modifier
    Cangrelor 50mg powder for solution for injection vials 10 vial Has specific active ingredient False Cangrelor tetrasodium Inferred relationship Existential restriction modifier
    Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) 10 vial Has specific active ingredient False Cangrelor tetrasodium Inferred relationship Existential restriction modifier
    Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (Chiesi Ltd) Has specific active ingredient False Cangrelor tetrasodium Inferred relationship Existential restriction modifier
    Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (Chiesi Ltd) 10 vial Has specific active ingredient False Cangrelor tetrasodium Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start